CPDR ISSUED U.S. PATENTS

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
U.S.: Patent serial #12/444,903. Claims for EPC-1 and 2 issued September 2013.
Complete Document

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
Australia: Patent # 2007324128 has issued ERG-8 claims in January 2014.
Complete Document

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
Japan: Patent # 5470041, has issued ERG-8 in February 2014.

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
European Union: EPC-1 issued, serial # 12163605.4.

ERG Monoclonal Antibodies
U.S.: Patent serial # 13/266,908, notice of allowance to issue with claims that cover sequences specifically for 9FY Ab.
Complete Document

ERG Monoclonal Antibodies
European Union: Serial # 10770245.8 with broad claims to a monoclonal Ab that binds to the ERG epitope from 42-66.

Androgen-regulated PMEPA1 gene and polypeptides
U.S. Patent serial #7,537,896
Complete Document

Prostate-Specific Gene, PCGEM1, and the Methods of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer
U.S. Patent serial #6,828,429
Complete Document

Androgen-Regulated Gene Expressed in Prostate Tissue
U.S. Patent serial #6,566,130
Complete Document

 

Published U.S. Patent Applications:

Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer
Complete Document

Prostate cancer-specific alterations in ERG gene expression and detection and treatment methods based on those alterations
Complete Document

Androgen-Regulated PMEPA1 Gene and Polypeptides
Complete Document

Prostate-Specific Gene, PCGEM1, and Methods of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer
Complete Document

Method of Detecting Androgen-Regulated Gene
Complete Document

Enhanced Diagnostic Potential of Prostate-Specific Antigen Expressing Cells
Complete Document

 

Published PCT Applications:

Prostate Cancer-Specific Alterations in ERG Gene Expression and Detection and Treatment Methods Based on Those Alterations
Complete Document

Prostate-Specific Gene, PCGEM1, and Methods of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer
Complete Document

Enhanced Diagnostic Potential of Prostate-Specific Antigen Expressing Cells*
Complete Document

Androgen-Regulated PMEPA1 and Cancer
Complete Document